Stay updated on ABTL0812 in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the ABTL0812 in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABTL0812 in Pancreatic Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the dosage levels of the investigational drug ABTL0812 in a clinical trial for patients with advanced metastatic pancreatic cancer undergoing first-line therapy.
    Difference
    0.1%
    Check dated 2024-06-06T14:47:04.000Z thumbnail image
  5. Check
    6 days ago
    No Change Detected
  6. Check
    18 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments. The new description emphasizes the importance of these criteria in selecting participants for clinical research.
    Difference
    45%
    Check dated 2024-05-22T21:31:47.000Z thumbnail image
  7. Check
    40 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:31:06.000Z thumbnail image

Stay in the know with updates to ABTL0812 in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABTL0812 in Pancreatic Cancer Clinical Trial page.